This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tanaka, K. Articles by Tanigawa, N. Search for Related Content PubMed PubMed Citation Articles by Tanaka, K. Articles by Tanigawa, N.

Expression of survivin and Its Relationship to Loss of Apoptosis in Breast Carcinomas

Department of General and Gastroenterological Surgery, Osaka Medical College, Takatsuki City, Osaka 569-8686, Japan

Aberrant inhibition of programmed cell death (apoptosis) prevents normal homeostasis and promotes tissue tumorigenesis, but whether it also influences the outcome of common cancers has remained arguable. The expression of a novel IAP apoptosis inhibitor, survivin, in breast cancer and its association with tumor cell apoptosis and overall prognosis were examined in this study. Immunohistochemical analysis showed that survivin expression was positive in 118 of 167 cases (70.7%) of breast carcinomas of histological stages I to III. In contrast, no expression of survivin in adjacent normal tissue was detected. Although survivin expression was not correlated with p53 mutations, survivin-positive cases were strongly associated with bcl-2 expression (78.0% versus 47.5%; P = 0.0005) and reduced apoptotic index (0.62% ± 0.51% versus 1.27% ± 1.37%; P < 0.0001). In addition, patients with low apoptotic index (<0.52%) had worse survival rates than the group with high apoptotic index (0.52%; P = 0.028), and multivariate Cox proportional hazard model analysis identified apoptotic index as an independent prognostic factor (P = 0.024). The results suggest that apoptosis inhibition by survivin, alone or in cooperation with bcl-2, is a significant prognostic parameter of worse outcome in breast carcinoma.

This article has been cited by other articles:

				S. Banerjee, A. O. Kaseb, Z. Wang, D. Kong, M. Mohammad, S. Padhye, F. H. Sarkar, and R. M. Mohammad Antitumor Activity of Gemcitabine and Oxaliplatin Is Augmented by Thymoquinone in Pancreatic Cancer Cancer Res., July 1, 2009; 69(13): 5575 - 5583. [Abstract] [Full Text] [PDF]

				T. Satoh, I. Okamoto, M. Miyazaki, R. Morinaga, A. Tsuya, Y. Hasegawa, M. Terashima, S. Ueda, M. Fukuoka, Y. Ariyoshi, et al. Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors Clin. Cancer Res., June 1, 2009; 15(11): 3872 - 3880. [Abstract] [Full Text] [PDF]

				K. W. Rahman, S. Banerjee, S. Ali, A. Ahmad, Z. Wang, D. Kong, and W. A. Sakr 3,3'-Diindolylmethane Enhances Taxotere-Induced Apoptosis in Hormone-Refractory Prostate Cancer Cells through Survivin Down-regulation Cancer Res., May 15, 2009; 69(10): 4468 - 4475. [Abstract] [Full Text] [PDF]

				K. Y. Song, C. K. Jung, W. S. Park, and C. H. Park Expression of the Antiapoptosis Gene Survivin Predicts Poor Prognosis of Stage III Gastric Adenocarcinoma Jpn. J. Clin. Oncol., May 1, 2009; 39(5): 290 - 296. [Abstract] [Full Text] [PDF]

				T. Minematsu, M. Iwai, K. Sugimoto, N. Shirai, T. Nakahara, T. Usui, and H. Kamimura Carrier-Mediated Uptake of 1-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazolium Bromide (YM155 Monobromide), a Novel Small-Molecule Survivin Suppressant, into Human Solid Tumor and Lymphoma Cells Drug Metab. Dispos., March 1, 2009; 37(3): 619 - 628. [Abstract] [Full Text] [PDF]

				T. Liu, Y. Niu, Y. Yu, Y. Liu, and F. Zhang Increased {gamma}-tubulin expression and P16INK4A promoter methylation occur together in preinvasive lesions and carcinomas of the breast Ann. Onc., March 1, 2009; 20(3): 441 - 448. [Abstract] [Full Text] [PDF]

				A. C. Mita, M. M. Mita, S. T. Nawrocki, and F. J. Giles Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics Clin. Cancer Res., August 15, 2008; 14(16): 5000 - 5005. [Abstract] [Full Text] [PDF]

				J. Wang, L. Yang, J. Yang, K. Kuropatwinski, W. Wang, X.-Q. Liu, J. Hauser, and M. G. Brattain Transforming Growth Factor {beta} Induces Apoptosis through Repressing the Phosphoinositide 3-Kinase/AKT/Survivin Pathway in Colon Cancer Cells Cancer Res., May 1, 2008; 68(9): 3152 - 3160. [Abstract] [Full Text] [PDF]

				D. J. Brennan, E. Rexhepaj, S. L. O'Brien, E. McSherry, D. P. O'Connor, A. Fagan, A. C. Culhane, D. G. Higgins, K. Jirstrom, R. C. Millikan, et al. Altered Cytoplasmic-to-Nuclear Ratio of Survivin Is a Prognostic Indicator in Breast Cancer Clin. Cancer Res., May 1, 2008; 14(9): 2681 - 2689. [Abstract] [Full Text] [PDF]

				H. Hu, Y. Shikama, I. Matsuoka, and J. Kimura Terminally differentiated neutrophils predominantly express Survivin-2{alpha}, a dominant-negative isoform of Survivin J. Leukoc. Biol., February 1, 2008; 83(2): 393 - 400. [Abstract] [Full Text] [PDF]

				T. Nakahara, M. Takeuchi, I. Kinoyama, T. Minematsu, K. Shirasuna, A. Matsuhisa, A. Kita, F. Tominaga, K. Yamanaka, M. Kudoh, et al. YM155, a Novel Small-Molecule Survivin Suppressant, Induces Regression of Established Human Hormone-Refractory Prostate Tumor Xenografts Cancer Res., September 1, 2007; 67(17): 8014 - 8021. [Abstract] [Full Text] [PDF]

				A. Sayeed, S. D. Konduri, W. Liu, S. Bansal, F. Li, and G. M. Das Estrogen Receptor {alpha} Inhibits p53-Mediated Transcriptional Repression: Implications for the Regulation of Apoptosis Cancer Res., August 15, 2007; 67(16): 7746 - 7755. [Abstract] [Full Text] [PDF]

				A. Troeger, M. Siepermann, G. Escherich, R. Meisel, R. Willers, S. Gudowius, T. Moritz, H.-J. Laws, H. Hanenberg, U. Goebel, et al. Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia Haematologica, August 1, 2007; 92(8): 1043 - 1050. [Abstract] [Full Text] [PDF]

				R. Kaneko, N. Tsuji, K. Asanuma, H. Tanabe, D. Kobayashi, and N. Watanabe Survivin Down-regulation Plays a Crucial Role in 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitor-induced Apoptosis in Cancer J. Biol. Chem., July 6, 2007; 282(27): 19273 - 19281. [Abstract] [Full Text] [PDF]

				S. Pina-Oviedo, K. Urbanska, S. Radhakrishnan, T. Sweet, K. Reiss, K. Khalili, and L. Del Valle Effects of JC Virus Infection on Anti-Apoptotic Protein Survivin in Progressive Multifocal Leukoencephalopathy Am. J. Pathol., April 1, 2007; 170(4): 1291 - 1304. [Abstract] [Full Text] [PDF]

				P. Kumar, I. K. Coltas, B. Kumar, D. B. Chepeha, C. R. Bradford, and P. J. Polverini Bcl-2 Protects Endothelial Cells against {gamma}-Radiation via a Raf-MEK-ERK-Survivin Signaling Pathway That Is Independent of Cytochrome c Release Cancer Res., February 1, 2007; 67(3): 1193 - 1202. [Abstract] [Full Text] [PDF]

				X.-H. Peng, P. Karna, R. M. O'Regan, X. Liu, R. Naithani, R. M. Moriarty, W. C. Wood, H.-Y. Lee, and L. Yang Down-Regulation of Inhibitor of Apoptosis Proteins by Deguelin Selectively Induces Apoptosis in Breast Cancer Cells Mol. Pharmacol., January 1, 2007; 71(1): 101 - 111. [Abstract] [Full Text] [PDF]

				N. Cosgrave, A. D K Hill, and L. S Young Growth factor-dependent regulation of survivin by c-myc in human breast cancer J. Mol. Endocrinol., December 1, 2006; 37(3): 377 - 390. [Abstract] [Full Text] [PDF]

				X.-H. Peng, P. Karna, Z. Cao, B.-H. Jiang, M. Zhou, and L. Yang Cross-talk between Epidermal Growth Factor Receptor and Hypoxia-inducible Factor-1{alpha} Signal Pathways Increases Resistance to Apoptosis by Up-regulating Survivin Gene Expression J. Biol. Chem., September 8, 2006; 281(36): 25903 - 25914. [Abstract] [Full Text] [PDF]

				P. N. Span, V. C.G. Tjan-Heijnen, J. J.T.M. Heuvel, J. B. de Kok, J. A. Foekens, and F. C.G.J. Sweep Do the Survivin (BIRC5) Splice Variants Modulate or Add to the Prognostic Value of Total Survivin in Breast Cancer? Clin. Chem., September 1, 2006; 52(9): 1693 - 1700. [Abstract] [Full Text] [PDF]

				S. Fukuda and L. M. Pelus Survivin, a cancer target with an emerging role in normal adult tissues Mol. Cancer Ther., May 1, 2006; 5(5): 1087 - 1098. [Abstract] [Full Text] [PDF]

				B. M. Ryan, G. E. Konecny, S. Kahlert, H.-J. Wang, M. Untch, G. Meng, M. D. Pegram, K. C. Podratz, J. Crown, D. J. Slamon, et al. Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1 Ann. Onc., April 1, 2006; 17(4): 597 - 604. [Abstract] [Full Text] [PDF]

				W. Xia, J. Bisi, J. Strum, L. Liu, K. Carrick, K. M. Graham, A. L. Treece, M. A. Hardwicke, M. Dush, Q. Liao, et al. Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers Cancer Res., February 1, 2006; 66(3): 1640 - 1647. [Abstract] [Full Text] [PDF]

				T. Gritsko, A. Williams, J. Turkson, S. Kaneko, T. Bowman, M. Huang, S. Nam, I. Eweis, N. Diaz, D. Sullivan, et al. Persistent Activation of Stat3 Signaling Induces Survivin Gene Expression and Confers Resistance to Apoptosis in Human Breast Cancer Cells Clin. Cancer Res., January 1, 2006; 12(1): 11 - 19. [Abstract] [Full Text] [PDF]

				H. Asanuma, T. Torigoe, K. Kamiguchi, Y. Hirohashi, T. Ohmura, K. Hirata, M. Sato, and N. Sato Survivin Expression Is Regulated by Coexpression of Human Epidermal Growth Factor Receptor 2 and Epidermal Growth Factor Receptor via Phosphatidylinositol 3-Kinase/AKT Signaling Pathway in Breast Cancer Cells Cancer Res., December 1, 2005; 65(23): 11018 - 11025. [Abstract] [Full Text] [PDF]

				J. G. Hodgson, T. Malek, S. Bornstein, S. Hariono, D. G. Ginzinger, W. J. Muller, and J. W. Gray Copy Number Aberrations in Mouse Breast Tumors Reveal Loci and Genes Important in Tumorigenic Receptor Tyrosine Kinase Signaling Cancer Res., November 1, 2005; 65(21): 9695 - 9704. [Abstract] [Full Text] [PDF]

				Y. Fujie, H. Yamamoto, C. Y. Ngan, A. Takagi, T. Hayashi, R. Suzuki, K. Ezumi, I. Takemasa, M. Ikeda, M. Sekimoto, et al. Oxaliplatin, a Potent Inhibitor of Survivin, Enhances Paclitaxel-induced Apoptosis and Mitotic Catastrophe in Colon Cancer Cells Jpn. J. Clin. Oncol., August 1, 2005; 35(8): 453 - 463. [Abstract] [Full Text] [PDF]

				D. A. Fennell Caspase Regulation in Non-Small Cell Lung Cancer and its Potential for Therapeutic Exploitation Clin. Cancer Res., March 15, 2005; 11(6): 2097 - 2105. [Abstract] [Full Text] [PDF]

				X.-H. Peng, Z.-H. Cao, J.-T. Xia, G. W. Carlson, M. M. Lewis, W. C. Wood, and L. Yang Real-time Detection of Gene Expression in Cancer Cells Using Molecular Beacon Imaging: New Strategies for Cancer Research Cancer Res., March 1, 2005; 65(5): 1909 - 1917. [Abstract] [Full Text] [PDF]

				S. Idenoue, Y. Hirohashi, T. Torigoe, Y. Sato, Y. Tamura, H. Hariu, M. Yamamoto, T. Kurotaki, T. Tsuruma, H. Asanuma, et al. A Potent Immunogenic General Cancer Vaccine That Targets Survivin, an Inhibitor of Apoptosis Proteins Clin. Cancer Res., February 15, 2005; 11(4): 1474 - 1482. [Abstract] [Full Text] [PDF]

				M. H. Andersen, I. M. Svane, P. Kvistborg, O. J. Nielsen, E. Balslev, S. Reker, J. C. Becker, and P. t. Straten Immunogenicity of Bcl-2 in patients with cancer Blood, January 15, 2005; 105(2): 728 - 734. [Abstract] [Full Text] [PDF]

				E. Pizzoferrato, Y. Liu, A. Gambotto, M. J. Armstrong, M. T. Stang, W. E. Gooding, S. M. Alber, S. H. Shand, S. C. Watkins, W. J. Storkus, et al. Ectopic Expression of Interferon Regulatory Factor-1 Promotes Human Breast Cancer Cell Death and Results in Reduced Expression of Survivin Cancer Res., November 15, 2004; 64(22): 8381 - 8388. [Abstract] [Full Text] [PDF]

				P. N. Span, F. C.G.J. Sweep, E. T.G. Wiegerinck, V. C.G. Tjan-Heijnen, P. Manders, L. V.A.M. Beex, and J. B. de Kok Survivin Is an Independent Prognostic Marker for Risk Stratification of Breast Cancer Patients Clin. Chem., November 1, 2004; 50(11): 1986 - 1993. [Abstract] [Full Text] [PDF]

				A. D. Schimmer Inhibitor of Apoptosis Proteins: Translating Basic Knowledge into Clinical Practice Cancer Res., October 15, 2004; 64(20): 7183 - 7190. [Abstract] [Full Text] [PDF]

				K. H. Emami, C. Nguyen, H. Ma, D. H. Kim, K. W. Jeong, M. Eguchi, R. T. Moon, J.-L. Teo, S. W. Oh, H. Y. Kim, et al. A small molecule inhibitor of {beta}-catenin/CREB-binding protein transcription PNAS, August 24, 2004; 101(34): 12682 - 12687. [Abstract] [Full Text] [PDF]

				N. Zahir, J. N. Lakins, A. Russell, W. Ming, C. Chatterjee, G. I. Rozenberg, M. P. Marinkovich, and V. M. Weaver Autocrine laminin-5 ligates {alpha}6{beta}4 integrin and activates RAC and NF{kappa}B to mediate anchorage-independent survival of mammary tumors J. Cell Biol., December 22, 2003; 163(6): 1397 - 1407. [Abstract] [Full Text] [PDF]

				V. Pisarev, B. Yu, R. Salup, S. Sherman, D. C. Altieri, and D. I. Gabrilovich Full-Length Dominant-Negative Survivin for Cancer Immunotherapy Clin. Cancer Res., December 15, 2003; 9(17): 6523 - 6533. [Abstract] [Full Text] [PDF]

				J. E. Korkola, S. DeVries, J. Fridlyand, E. S. Hwang, A. L. H. Estep, Y.-Y. Chen, K. L. Chew, S. H. Dairkee, R. M. Jensen, and F. M. Waldman Differentiation of Lobular versus Ductal Breast Carcinomas by Expression Microarray Analysis Cancer Res., November 1, 2003; 63(21): 7167 - 7175. [Abstract] [Full Text] [PDF]

				L. Yang, Z. Cao, H. Yan, and W. C. Wood Coexistence of High Levels of Apoptotic Signaling and Inhibitor of Apoptosis Proteins in Human Tumor Cells: Implication for Cancer Specific Therapy Cancer Res., October 15, 2003; 63(20): 6815 - 6824. [Abstract] [Full Text] [PDF]

				C. Tanaka, K. Uzawa, T. Shibahara, H. Yokoe, H. Noma, and H. Tanzawa Expression of an Inhibitor of Apoptosis, Survivin, in Oral Carcinogenesis Journal of Dental Research, August 1, 2003; 82(8): 607 - 611. [Abstract] [Full Text] [PDF]

				S. Paydas, K. Tanriverdi, S. Yavuz, U. Disel, B. Sahin, and R. Burgut Survivin and aven: two distinct antiapoptotic signals in acute leukemias Ann. Onc., July 1, 2003; 14(7): 1045 - 1050. [Abstract] [Full Text] [PDF]

				M. Kappler, M. Kotzsch, F. Bartel, S. Fussel, C. Lautenschlager, U. Schmidt, P. Wurl, M. Bache, H. Schmidt, H. Taubert, et al. Elevated Expression Level of Survivin Protein in Soft-Tissue Sarcomas Is a Strong Independent Predictor of Survival Clin. Cancer Res., March 1, 2003; 9(3): 1098 - 1104. [Abstract] [Full Text] [PDF]

				R. Bao, D. C. Connolly, M. Murphy, J. Green, J. K. Weinstein, D. A. Pisarcik, and T. C. Hamilton Activation of Cancer-Specific Gene Expression by the Survivin Promoter J Natl Cancer Inst, April 3, 2002; 94(7): 522 - 528. [Abstract] [Full Text] [PDF]

				A. Chakravarti, E. Noll, P. McL. Black, D. F. Finkelstein, D. M. Finkelstein, N. J. Dyson, and J. S. Loeffler Quantitatively Determined Survivin Expression Levels Are of Prognostic Value in Human Gliomas J. Clin. Oncol., February 15, 2002; 20(4): 1063 - 1068. [Abstract] [Full Text] [PDF]

				J. P. Carson, M. Behnam, J. N. Sutton, C. Du, X. Wang, D. F. Hunt, M. J. Weber, and G. Kulik Smac Is Required for Cytochrome c-induced Apoptosis in Prostate Cancer LNCaP Cells Cancer Res., January 1, 2002; 62(1): 18 - 23. [Abstract] [Full Text] [PDF]

				J. R. Kanwar, W.-P. Shen, R. K. Kanwar, R. W. Berg, and G. W. Krissansen Effects of Survivin Antagonists on Growth of Established Tumors and B7-1 Immunogene Therapy J Natl Cancer Inst, October 17, 2001; 93(20): 1541 - 1552. [Abstract] [Full Text] [PDF]

				S. Fukuda and L. M. Pelus Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34+ cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis Blood, October 1, 2001; 98(7): 2091 - 2100. [Abstract] [Full Text] [PDF]

				A. Yagihashi, K. Asanuma, M. Nakamura, J. Araya, Y. Mano, T. Torigoe, D. Kobayashi, and N. Watanabe Detection of Anti-Survivin Antibody in Gastrointestinal Cancer Patients Clin. Chem., September 1, 2001; 47(9): 1729 - 1731. [Full Text] [PDF]

				B. Z. Carter, M. Milella, D. C. Altieri, and M. Andreeff Cytokine-regulated expression of survivin in myeloid leukemia Blood, May 1, 2001; 97(9): 2784 - 2790. [Abstract] [Full Text] [PDF]

				S. D. Smith, M. A. Wheeler, J. Plescia, J. W. Colberg, R. M. Weiss, and D. C. Altieri Urine Detection of Survivin and Diagnosis of Bladder Cancer JAMA, January 17, 2001; 285(3): 324 - 328. [Abstract] [Full Text] [PDF]

				M. Shibakita, M. Tachibana, D. K. Dhar, S. Ohno, H. Kubota, H. Yoshimura, S. Kinugasa, R. Masunaga, and N. Nagasue Spontaneous Apoptosis in Advanced Esophageal Carcinoma: Its Relation to Fas Expression Clin. Cancer Res., December 1, 2000; 6(12): 4755 - 4759. [Abstract] [Full Text]

				D. Grossman, P. J. Kim, J. S. Schechner, and D. C. Altieri Inhibition of melanoma tumor growth in vivo by survivin targeting PNAS, January 16, 2001; 98(2): 635 - 640. [Abstract] [Full Text] [PDF]